Ioannis Roxanis

4PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 28, 2026
A Randomized, Phase II Clinical Trial of FLT-PET and FDG-PET for Early Response Assessment of Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.

|May 21, 2024
Anti-EGFR Antibody-Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth.

Anthony Cheung, Alicia M Chenoweth, Annelie Johansson

|Aug 13, 2023
Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727).

Holly Tovey, Orsolya Sipos, Joel S Parker

|Sep 26, 2022
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers.

Patrycja Gazinska, Charlotte Milton, Jacopo Iacovacci

Pageof 1

Frequent Collaborators

4 joint publications

Syed Haider

4 joint publications

Andrew Tutt

3 joint publications

Patrycja Gazinska

3 joint publications

Sheeba Irshad